AeroLeads people directory · profile

Weiwei Liang Email & Phone Number

Vice President Business Development; Assets cross TAs; Innovative Technologies; AI/ML; BD&L, Equity Investment, M&A at Transcenta
Location: New York City Metropolitan Area, United States 11 work roles 2 schools
1 work email found @bms.com LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email w****@bms.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Vice President Business Development; Assets cross TAs; Innovative Technologies; AI/ML; BD&L, Equity Investment, M&A
Location
New York City Metropolitan Area, United States

Who is Weiwei Liang? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Weiwei Liang is listed as Vice President Business Development; Assets cross TAs; Innovative Technologies; AI/ML; BD&L, Equity Investment, M&A at Transcenta, based in New York City Metropolitan Area, United States. AeroLeads shows a work email signal at bms.com and a matched LinkedIn profile for Weiwei Liang.

Weiwei Liang previously worked as Vice President, Business Development Transaction and Corporate Strategy at Transcenta and Senior Director Business Development at Bristol Myers Squibb. Weiwei Liang holds Mba, Finance, Product Operations Management, Quantitative Analysis from Carnegie Mellon University - Tepper School Of Business.

Company email context

Email format at Transcenta

This section adds company-level context without repeating Weiwei Liang's masked contact details.

{first}.{last}@bms.com
86% confidence

AeroLeads found 1 current-domain work email signal for Weiwei Liang. Compare company email patterns before reaching out.

Profile bio

About Weiwei Liang

Weiwei Liang is an adaptable business leader with a passion for innovation. Throughout his career, he has held key positions with increasing responsibility in Business Development (BD), commercial, finance, and technology functions at Bristol Myers Squibb, Novartis, Bayer, and IBM. With over 20 years of global cross-functional experience, Weiwei has excelled in forming business strategies, leading complex transactions in BD, equity investment, and mergers and acquisitions (M&A), and achieving notable sales and margin increases.Previously serving as Senior Director of BD at Bristol Myers Squibb, Weiwei is dedicated to transforming the discovery, development, and delivery of medicines and healthcare solutions, leveraging the latest groundbreaking innovations such as Artificial Intelligence (AI) and Machine Learning across all therapeutic areas and the entire healthcare value chain. He has spearheaded significant collaborations and investments, including his company's first Multimodal AI drug discovery strategic partnership, the first AI-designed biologics research and licensing collaboration, and the first digital therapeutics collaboration. Notable publicly announced transactions led by Weiwei include CHARM Tx, Tempus AI, Terray Tx, Nabla Bio and Elekta/Kaiku. Weiwei possesses experience in various transaction types, including licensing, collaboration, co-promotion, equity investment, M&A, and divestment. His expertise also spans a wide range of assets, from molecule assets (early to late stage, innovative medicines to biosimilars and generics) to medical devices, technologies, and digital therapeutics. The total value of the deals he has led exceeds USD $2 billion.Prior to his business development career, Weiwei held various key positions in commercial, strategy, portfolio management, and BD/M&A finance. In these roles, he was responsible for developing business strategies, driving the launch of new products and solutions, as well as conducting commercial assessments and financial modeling for strategic partnerships and M&A transactions. Earlier in his career, he held leadership positions in finance controlling, and received recognition/president’s award for his roles in sales/key account management. Additionally, Weiwei has served as a board director at early-stage MedTech companies.Weiwei holds an MBA from Carnegie Mellon University – Tepper School of Business and a bachelor’s degree in Electrical and Electronics Engineering (with highest distinction) from Beijing University of Technology.

Listed skills include Strategic Planning, Business Development, Mergers, Cross Functional Team Leadership, and 20 others.

Current workplace

Weiwei Liang's current company

Company context helps verify the profile and gives searchers a useful next step.

Transcenta
Transcenta
Vice President Business Development; Assets cross TAs; Innovative Technologies; AI/ML; BD&L, Equity Investment, M&A
AeroLeads page
11 roles · 28 years

Weiwei Liang work experience

A career timeline built from the work history available for this profile.

Vice President, Business Development Transaction And Corporate Strategy

Current

Princeton, Us

Member of Corporate Leadership Team at Transcenta (HKG: 6628)

Aug 2024 - Present

Senior Director Business Development

Lawrence Township, Nj, Us

Area of focus: global BD&L S&E and transaction lead (licensing, collaboration, investment and acquisition) of opportunities leveraging data and digital innovations (e.g. AI, ML) to enhance and transform discovery, development and delivery of medicines.Novel transactions that have been publicly announced:

2021 - Jul 2024

Director Business Development And Licensing - Deal Lead

Basel, Baselstadt, Ch

Division: SandozAreas of focus: lead complex BD&L deals (licensing, acquisition and divestment of NCEs, Biologics, complex generics, biosimilars, digital therapeutics in TAs incl. oncology, immunology, CNS, cardiology, endocrinology etc.) and cross functional/global teams, from deal initiation, assessment, structuring, negotiation, due diligence, contracting to deal closing.Promoted to Director

2018 - 2021 ~3 yrs

Associate Director Us Commercial Strategy And Business Operations

Basel, Baselstadt, Ch

Business Franchise: Immunology, Hepatology and DermatologySpecialty: Immunology, Dermatology, Transplantation, Immunology Rare Disease• US Commercial Strategy and Operations launching Multi-Blockbuster biologic Cosentyx• BD&L, Commercial Assessment and Strategic Planning• Management & Investor Relations Support

2016 - 2018 ~2 yrs

Board Director

Bloomington, Mn, Us

i-Lumen Scientific is a medical technology company pioneering a new field of treatment in electrical medicine, "Neural Retinal Therapy”™, to restore eyesight to patients afflicted with dry age-related macular degeneration (AMD).

2018 - 2020 ~2 yrs

Board Director, Advisor

Amerivision
2017 - 2018 ~1 yr

Associate Director Global Strategic Marketing, Strategy And Portfolio Management

Leverkusen, North Rhine-Westphalia, De

Specialty: Radiology and Interventional, incl. health informatics. • Strategic Evaluations, BD&L and Commercial Assessment• Portfolio Management and New Product Offerings• Business Analytics and Executive Management Support

2014 - 2016 ~2 yrs

Progressive Roles In Corporate, Bd&L And M&A Finance, Corporate Planning And Business Analysis

Leverkusen, North Rhine-Westphalia, De

Performance exceeding expectations in last five years. 2013 to 2014 Manager, Business Analyst2011 to 2012 Financial Product Modeling Lead2009 to 2011 Manager, Financial Planning and Analysis2006 to 2009 Senior Financial Analyst• BD&L and M&A Finance• Portfolio Management and New Product Development rationalization• Finance and Controlling (leadership team member)• Global and Regional Strategic Planning• Emerging Market Strategy

2006 - 2014 ~8 yrs

Mba Management Intern

Pittsburgh, Pa, Us

• Business Development• Market Assessment • M&A and Investment Project Financials

May 2005 - Aug 2005

Technical Program Lead

Ibm

Armonk, New York, Ny, Us

• Operational Excellence• Management Support

2003 - 2004 ~1 yr

Key Account Lead

Ibm

Armonk, New York, Ny, Us

• Key Account Management, President Award for winning the largest service contract of the year• Contract Negotiation• Engineering Project Management

1999 - 2003 ~4 yrs
2 education records

Weiwei Liang education

Mba, Finance, Product Operations Management, Quantitative Analysis

Carnegie Mellon University - Tepper School Of Business

Bachelor'S Degree, Electrical And Electronics Engineering

Beijing University Of Technology
FAQ

Frequently asked questions about Weiwei Liang

Quick answers generated from the profile data available on this page.

What company does Weiwei Liang work for?

Weiwei Liang works for Transcenta.

What is Weiwei Liang's role at Transcenta?

Weiwei Liang is listed as Vice President Business Development; Assets cross TAs; Innovative Technologies; AI/ML; BD&L, Equity Investment, M&A at Transcenta.

What is Weiwei Liang's email address?

AeroLeads has found 1 work email signal at @bms.com for Weiwei Liang at Transcenta.

Where is Weiwei Liang based?

Weiwei Liang is based in New York City Metropolitan Area, United States while working with Transcenta.

What companies has Weiwei Liang worked for?

Weiwei Liang has worked for Transcenta, Bristol Myers Squibb, Novartis, I-Lumen Scientific, Inc., and Amerivision.

How can I contact Weiwei Liang?

You can use AeroLeads to view verified contact signals for Weiwei Liang at Transcenta, including work email, phone, and LinkedIn data when available.

What schools did Weiwei Liang attend?

Weiwei Liang holds Mba, Finance, Product Operations Management, Quantitative Analysis from Carnegie Mellon University - Tepper School Of Business.

What skills is Weiwei Liang known for?

Weiwei Liang is listed with skills including Strategic Planning, Business Development, Mergers, Cross Functional Team Leadership, Business Analysis, Corporate Finance, Mergers And Acquisitions, and Entrepreneurship.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.